Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions
International Journal of Molecular Sciences · 14.03.2024 · 25 (6) · 3319
DOI: 10.3390/ijms25063319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.03.2024. Verfasst von Shuo Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Frailty, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
The population of cancer survivors has markedly increased due to the rapid improvements in cancer treatment. However, cancer survivors experience accelerated aging, which leads to chronic diseases and other age-related conditions, such as frailty. Those conditions may persist years after cancer diagnosis and treatment. Cellular senescence, a hallmark of aging, is one of the mechanisms that contribute to accelerated aging in cancer survivors. Several aging measures, including measures based on clinical markers and biomarkers, have been proposed to estimate the aging process, and some of them have shown associations with mortality and frailty in cancer survivors. Several anti-aging interventions, including lifestyle changes and anti-aging drugs, have been proposed. Future research, particularly in large-scale studies, is needed to determine the efficiency of these aging measures and anti-aging interventions before considering their application in clinics. This review focuses on the mechanisms of cellular senescence and accelerated aging in cancer survivors, assessment of the aging process using clinical markers and biomarkers, and the high prevalence of frailty in that population, as well as possible opportunities for anti-aging interventions. A deeper understanding of aging measures and anti-aging interventions in cancer survivors will contribute to the development of effective strategies to mitigate accelerated aging in cancer survivors and improve their quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
- Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Shuo Wang, Anna Prizment
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Wang, S., El Jurdi, N., Thyagarajan, B., Prizment, A., & Blaes, A. H. (2024). Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions. International Journal of Molecular Sciences, 25(6), 3319. https://doi.org/10.3390/ijms25063319
Vancouver
Wang S, El Jurdi N, Thyagarajan B, Prizment A, Blaes AH. Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions. International Journal of Molecular Sciences. 2024;25(6):3319. doi:10.3390/ijms25063319
BibTeX
@article{Wang2024,
author = {Wang, Shuo and El Jurdi, Najla and Thyagarajan, Bharat and Prizment, Anna and Blaes, Anne H},
title = {Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {6},
pages = {3319},
doi = {10.3390/ijms25063319}
}
EUVIMED